Menu
Search
|

Menu

Close
X

Veru Inc VERU.OQ (NASDAQ Stock Exchange Capital Market)

1.34 USD
+0.02 (+1.52%)
As of 10:46 AM EST
chart
Previous Close 1.32
Open 1.32
Volume 11,097
3m Avg Volume 19,836
Today’s High 1.34
Today’s Low 1.32
52 Week High 2.99
52 Week Low 0.90
Shares Outstanding (mil) 53.51
Market Capitalization (mil) 70.64
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY18
3
FY17
14
FY16
22
FY15
33
EPS (USD)
FY18
-0.080
FY17
-0.229
FY16
0.011
FY15
0.153
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
34.59
Price to Sales (TTM)
vs sector
5.43
8.08
Price to Book (MRQ)
vs sector
1.58
5.24
Price to Cash Flow (TTM)
vs sector
--
25.98
Total Debt to Equity (MRQ)
vs sector
0.00
15.60
LT Debt to Equity (MRQ)
vs sector
0.00
12.18
Return on Investment (TTM)
vs sector
-18.82
13.67
Return on Equity (TTM)
vs sector
-28.74
15.40

EXECUTIVE LEADERSHIP

Elgar Peerschke
Chairman of the Board, Since 2016
Salary: --
Bonus: --
Mitchell Steiner
President, Chief Executive Officer, Director, Since 2016
Salary: --
Bonus: --
Overton Parrish
Vice Chairman of the Board, Since 2016
Salary: $169,908.00
Bonus: --
Mario Eisenberger
Director, Since 2016
Salary: --
Bonus: --
Harry Fisch
Director, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

4400 Biscayne Blvd Ste 888
MIAMI   FL   33137-3212

Phone: +1312.5959123

Veru Inc., formerly The Female Health Company, is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men's and women's health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector. For men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout and sexual dysfunction. Women's Health has product candidates for female sexual health, and advanced breast and ovarian cancers. It manufactures, markets and sells the FC2 Female Condom. FC2 provides dual protection against unintended pregnancy and sexually transmitted infections (STIs), including human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS).

SPONSORED STORIES